Regulators halt Sun Pharma eye-drop production at Assam plant
CDSCO and Assam's drugs controller ordered India's largest drugmaker to stop making, selling and distributing ophthalmic products from its Kokjhar facility after a joint inspection found quality-system failures, Reuters reported.
Ankur Borthakur (AI) · , 30 Oct 2026, 5:08 pm IST